{
    "cancelStatus": "0",
    "licStatus": "1",
    "cancelDate": null,
    "cancelReason": [],
    "otherCancelReason": "",
    "licid": "60000980",
    "licUnit": "1",
    "validDate": "2030-09-01 00:00:00.000",
    "issueDate": "2015-09-01 00:00:00.000",
    "oriIssueDate": "2015-09-01",
    "licKind": "04",
    "oldLicid": null,
    "certNo": "DHA06000098000",
    "prodNameC": "類克凍晶注射劑",
    "prodNameE": "Remicade powder for concentrate for solution for infusion",
    "indicationsName": [
        "1. 克隆氏症：適用於對傳統治療無效之成人中度至重度活動性克隆氏症，可減輕症狀與徵兆及誘導與維持臨床緩解；適用於對傳統治療(包含抗生素、引流與免疫抑制劑)反應不佳之成人活動性瘻管性克隆氏症。\r\n2. 小兒克隆氏症：適用於對皮質類固醇及免疫調節劑(immunomodulators)反應不佳之小兒(6-17歲)中度至重度活動性克隆氏症，可減輕症狀與徵兆及誘導與維持臨床緩解。\r\n3. 潰瘍性結腸炎：適用於對皮質類固醇和6-mercaptopurine (6-MP)或azathioprine (AZA)等傳統治療無效、無法耐受或有醫療禁忌之中度至重度活動性潰瘍性結腸炎成人病人。\r\n4. 小兒潰瘍性結腸炎：適用於對皮質類固醇和6-mercaptopurine (6-MP)或azathioprine (AZA)等傳統治療無效、無法耐受或有醫療禁忌之中度至重度活動性潰瘍性結腸炎小兒(6-17歲)病人。\r\n5. 類風濕性關節炎：與methotrexate併用，減緩中度到重度活動性疾病病人的徵兆及症狀，抑制結構性損傷的惡化，經HAQ-DI量表評估，可改善日常生活功能。\r\n6. 僵直性脊椎炎：減緩活動性疾病病人的徵兆及症狀。\r\n"
    ],
    "does": "2243",
    "packageUnit": [
        {
            "packageSpec": "100毫克",
            "packageUnit": "L2"
        },
        {
            "packageSpec": "100瓶以下",
            "packageUnit": "03"
        }
    ],
    "medMCode": "05",
    "maMedCode": "",
    "medDCode": null,
    "mainCategory": null,
    "drBaseId": "5CFBE9AD-267A-4D21-8394-D215C493DE12",
    "subCategory": [],
    "ingredientsDesc": [
        "Infliximab"
    ],
    "restraintItemsCode": [
        "02 輸 入",
        "07 新藥監視",
        "1D 須執行風險管理計畫",
        "51 免除銜接性臨床試驗",
        "67 成品已完成元素不純物評估(Option 1、2a、2b)"
    ],
    "applicantName": "台田藥品股份有限公司",
    "applicantAddr": "臺北市南港區市民大道七段8號14樓之1",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": null,
    "mdKind": [],
    "monitorDate": "2020-09-01",
    "licidNew": null,
    "licidOld": null,
    "manuImportDesc": "廠商未登錄資料",
    "licManuImport": "2",
    "factoryDtoList": [
        {
            "id": "19280D8C-8219-4EBB-885E-26B7378096BC",
            "factoryCode": "1",
            "factoryName": "CILAG AG.",
            "factoryAddr": "HOCHSTRASSE 201 CH-8200 SCHAFFHAUSEN SWITZERLAND",
            "factoryCompanyAddr": "VIA M. BUONARROTI 23 20093 COLOGNO MONZESE,ITALY",
            "countryCode": "CH",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FCH0015000",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        },
        {
            "id": "946E6F2D-E6BE-470A-A94B-3F5DB4AEEBF3",
            "factoryCode": "2",
            "factoryName": "JANSSEN BIOLOGICS B.V.",
            "factoryAddr": "EINSTEINWEG 101, 2333 CB LEIDEN, THE NETHERLANDS",
            "factoryCompanyAddr": "EINSTEINWEG 92, 2333 CD LEIDEN, THE NETHERLANDS",
            "countryCode": "NL",
            "processCode": [
                {
                    "value": "65",
                    "name": "主成分(drug substance)製造廠"
                }
            ],
            "processCodeStr": "65;主成分(drug substance)製造廠",
            "factoryKind": "M",
            "factoryNo": "FNL0059000",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        },
        {
            "id": "AEC797BE-F8EE-4A7E-AA06-1C170DC0621A",
            "factoryCode": "2",
            "factoryName": "JANSSEN BIOTECH INC.",
            "factoryAddr": "200 GREAT VALLEY PARKWAY MALVERN, PENNSYLVANIA 19355-1307, USA",
            "factoryCompanyAddr": null,
            "countryCode": "US",
            "processCode": [
                {
                    "value": "2G",
                    "name": "主成分製造及許可證持有者"
                }
            ],
            "processCodeStr": "2G;主成分製造及許可證持有者",
            "factoryKind": "M",
            "factoryNo": "FUS0789100",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": "9200081100",
            "ingredientsName": "Infliximab",
            "ingredientsDesc": "Infliximab",
            "concentDesc": "",
            "concent": "100.000000",
            "concentUnit": "001",
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "1"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "L04AB02"
        }
    ],
    "udiInfoList": [],
    "licBaseId": "BD5A5481-EB7C-4F27-95EE-6DF67807A475"
}